OBJECTIVES: The objective of this review was to depict the physiological and clinical
rationale for the use of vasopressin in hemodynamic support of organ donors. After …

The pathophysiological changes that occur after brain death lead to a progressive
deterioration in organ function. The limited number of organs available for transplantation …

Background Hormone replacement therapy (HRT) is becoming more common when
managing brain-dead donors. Arginine vasopressin (AVP) is associated with benefits but is …

BACKGROUND Hormone replacement therapy (HRT) use for donors with hemodynamic
instability is common. The purpose of this study was to determine the effect of HRT in donors …

There is a critical shortage of donor organs. According to the United Network for Organ
Sharing (UNOS), 20% of organs are discarded after procurement. Many of these may be …

In a prospective study, we documented the hemodynamic effects of conventional donor
maintenance in 24 brain-dead organ donors. Patients were then randomized to receive …

BACKGROUND: Hormone replacement therapy increases the number and quality of grafts
recovered from brain-dead organ donors. Arginine vasopressin (AVP) has also been shown …

Purpose The purpose was to evaluate the effects of the most commonly used cardiac donor
inotropes/vasopressors on subsequent post‐heart transplant survival. Methods Adult heart …

Background: Vasopressin (VP) shows promise as a pressor agent in animals and adult
human cardiac arrest and resuscitation, but has not been studied for pressor effect in …

Although nearly 10% of patients experience profound vasodilatory shock after
cardiopulmonary bypass, some patients remain refractory to traditional resuscitation. Among …